KRSNAA DIAGNOSTICS
|
KRSNAA DIAGNOSTICS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 31.27 | 24.03 | 17.60 | 19.78 | 21.78 |
| CEPS(Rs) | 59.16 | 51.39 | 40.69 | 36.91 | 34.96 |
| DPS(Rs) | 2.00 | 2.75 | 2.50 | 2.75 | 2.50 |
| Book NAV/Share(Rs) | 299.69 | 271.39 | 250.05 | 234.43 | 217.33 |
| Tax Rate(%) | 22.20 | 24.42 | 18.81 | 22.56 | 20.95 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.42 | 26.51 | 23.28 | 25.11 | 28.87 |
| EBIT Margin(%) | 21.32 | 17.76 | 13.96 | 18.04 | 23.05 |
| Pre Tax Margin(%) | 16.87 | 14.32 | 11.30 | 16.46 | 18.99 |
| PAT Margin (%) | 13.13 | 10.82 | 9.17 | 12.75 | 15.02 |
| Cash Profit Margin (%) | 24.83 | 23.14 | 21.20 | 23.79 | 24.10 |
| Performance Ratios | |||||
| ROA(%) | 6.55 | 6.34 | 5.47 | 6.96 | 7.81 |
| ROE(%) | 10.97 | 9.22 | 7.36 | 8.76 | 10.02 |
| ROCE(%) | 13.08 | 12.62 | 9.94 | 11.75 | 14.79 |
| Asset Turnover(x) | 0.50 | 0.59 | 0.60 | 0.55 | 0.52 |
| Sales/Fixed Asset(x) | 0.77 | 0.78 | 0.83 | 0.87 | 0.93 |
| Working Capital/Sales(x) | 1.67 | 6.57 | 4.43 | 3.94 | 2.14 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.30 | 1.29 | 1.21 | 1.15 | 1.08 |
| Receivable days | 135.38 | 115.54 | 73.45 | 49.07 | 46.38 |
| Inventory Days | 13.26 | 16.61 | 17.93 | 12.83 | 7.35 |
| Payable days | 163.42 | 193.48 | 186.90 | 343.02 | 467.93 |
| Valuation Parameters | |||||
| PER(x) | 16.66 | 32.68 | 34.93 | 23.26 | 22.29 |
| PCE(x) | 8.81 | 15.28 | 15.11 | 12.47 | 13.89 |
| Price/Book(x) | 1.74 | 2.89 | 2.46 | 1.96 | 2.23 |
| Yield(%) | 0.38 | 0.35 | 0.41 | 0.60 | 0.51 |
| EV/Net Sales(x) | 2.36 | 3.67 | 3.18 | 2.81 | 2.87 |
| EV/Core EBITDA(x) | 7.13 | 12.21 | 12.23 | 9.66 | 8.94 |
| EV/EBIT(x) | 11.05 | 20.68 | 22.78 | 15.57 | 12.46 |
| EV/CE(x) | 1.24 | 2.51 | 2.03 | 1.77 | 1.84 |
| M Cap / Sales | 2.19 | 3.54 | 3.20 | 2.97 | 3.35 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 7.75 | 15.74 | 27.20 | 6.95 | - |
| Core EBITDA Growth(%) | 18.36 | 33.92 | 13.67 | -3.22 | - |
| EBIT Growth(%) | 29.37 | 47.22 | -1.60 | -16.29 | - |
| PAT Growth(%) | 30.70 | 36.54 | -8.49 | -9.18 | - |
| EPS Growth(%) | 30.10 | 36.55 | -11.02 | -9.18 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.50 | 0.19 | 0.20 | 0.04 | 0.04 |
| Current Ratio(x) | 2.68 | 1.36 | 1.50 | 2.25 | 2.76 |
| Quick Ratio(x) | 2.59 | 1.26 | 1.37 | 1.99 | 2.69 |
| Interest Cover(x) | 4.79 | 5.17 | 5.25 | 11.42 | 5.68 |
| Total Debt/Mcap(x) | 0.29 | 0.07 | 0.08 | 0.02 | 0.02 |
Compare Financial Ratios of peers of KRSNAA DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KRSNAA DIAGNOSTICS | ₹1,785.7 Cr | 4.4% | 0.9% | -29.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹113,734.0 Cr | -9.6% | -8.1% | 8.2% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹87,987.2 Cr | -8.4% | -7.8% | -15.9% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹59,635.5 Cr | -7.6% | -9.3% | 13.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹57,603.3 Cr | -8% | -16.3% | -15.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,288.0 Cr | -5.3% | -10.5% | 1% | Stock Analytics | |
KRSNAA DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KRSNAA DIAGNOSTICS | 4.4% |
0.9% |
-29.9% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses
